SCHEMBL25724531

SCHEMBL25724531

Fc1c(Br)ccc2ncnc(N3CC4(CCNCC4)C3)c12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 10/20 0.41
▸ ALDH1A1 P00352 7/20 0.40
▸ HSD17B10 Q99714 6/20 0.40
▸ HPGD P15428 3/20 0.40
▸ CYP1A2 P05177 5/20 0.39
▸ HTT P42858 1/20 0.39
▸ TSHR P16473 4/20 0.38
▸ CYP2D6 P10635 5/20 0.35
▸ USP2 O75604 3/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ TP53 P04637 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25231891 0.83 AKT1 (0.38) AKT1ALDH1A1HSD17B10HPGDCYP1A2
SCHEMBL25274640 0.81 AKT1 (0.36) AKT1ALDH1A1HSD17B10HPGDCYP1A2
SCHEMBL31579068 0.76 MAP4K4 (0.43) ALDH1A1HSD17B10CYP2D6USP2CYP3A4
SCHEMBL30406184 0.72 OPRD1 (0.38) ALDH1A1HSD17B10HTTTSHRCYP2D6
SCHEMBL25273633 0.71 ALDH1A1 (0.51) AKT1ALDH1A1HSD17B10HPGDCYP1A2
SCHEMBL25272447 0.71 ALDH1A1 (0.37) AKT1ALDH1A1HSD17B10HPGDCYP1A2
SCHEMBL25277572 0.71 HTT (0.44) AKT1ALDH1A1HSD17B10HPGDCYP1A2
SCHEMBL25275560 0.70 PIM1 (0.48) ALDH1A1HSD17B10HPGDCYP1A2HTT
SCHEMBL30455740 0.70 HTT (0.44) ALDH1A1HSD17B10HPGDCYP1A2HTT
SCHEMBL25222339 0.70 HTT (0.44) ALDH1A1HSD17B10HPGDCYP1A2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107696-A2 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 — — WO disclosed
Send feedback